Cargando…

The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity

Niemann-Pick Type C1 (NPC1) disease is a fatal neurovisceral disorder caused by dysfunction of NPC1 protein, which plays a role in intracellular cholesterol trafficking. The cholesterol-chelating agent, 2-hydroxypropyl-β-cyclodextrin (HPβCD), is currently undergoing clinical trials for treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yingjie, Takahashi, Satoe, Homma, Kazuaki, Duan, Chongwen, Zheng, Jason, Cheatham, Mary Ann, Zheng, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151916/
https://www.ncbi.nlm.nih.gov/pubmed/30249300
http://dx.doi.org/10.1186/s40478-018-0599-9
_version_ 1783357255472644096
author Zhou, Yingjie
Takahashi, Satoe
Homma, Kazuaki
Duan, Chongwen
Zheng, Jason
Cheatham, Mary Ann
Zheng, Jing
author_facet Zhou, Yingjie
Takahashi, Satoe
Homma, Kazuaki
Duan, Chongwen
Zheng, Jason
Cheatham, Mary Ann
Zheng, Jing
author_sort Zhou, Yingjie
collection PubMed
description Niemann-Pick Type C1 (NPC1) disease is a fatal neurovisceral disorder caused by dysfunction of NPC1 protein, which plays a role in intracellular cholesterol trafficking. The cholesterol-chelating agent, 2-hydroxypropyl-β-cyclodextrin (HPβCD), is currently undergoing clinical trials for treatment of this disease. Though promising in alleviating neurological symptoms, HPβCD causes irreversible hearing loss in NPC1 patients and outer hair cell (OHC) death in animal models. We recently found that HPβCD-induced OHC death can be significantly alleviated in a mouse model lacking prestin, an OHC-specific motor protein required for the high sensitivity and sharp frequency selectivity of mammalian hearing. Since cholesterol status is known to influence prestin’s electromotility, we examined how prestin contributes to HPβCD-induced OHC death in the disease context using the NPC1 knockout (KO) mouse model (NPC1-KO). We found normal expression and localization of prestin in NPC1-KO OHCs. Whole-cell patch-clamp recordings revealed a significant depolarization of the voltage-operating point of prestin in NPC1-KO mice, suggesting reduced levels of cholesterol in the lateral membrane of OHCs that lack NPC1. OHC loss and elevated thresholds were found for high frequency regions in NPC1-KO mice, whose OHCs retained their sensitivity to HPβCD. To investigate whether prestin’s electromotile function contributes to HPβCD-induced OHC death, the prestin inhibitor salicylate was co-administered with HPβCD to WT and NPC1-KO mice. Neither oral nor intraperitoneal administration of salicylate mitigated HPβCD-induced OHC loss. To further determine the contribution of prestin’s electromotile function, a mouse model expressing a virtually nonelectromotile prestin protein (499-prestin) was subjected to HPβCD treatment. 499-prestin knockin mice showed no resistance to HPβCD-induced OHC loss. As 499-prestin maintains its ability to bind cholesterol, our data imply that HPβCD-induced OHC death is ascribed to the structural role of prestin in maintaining the OHC’s lateral membrane, rather than its motor function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-018-0599-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6151916
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61519162018-09-26 The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity Zhou, Yingjie Takahashi, Satoe Homma, Kazuaki Duan, Chongwen Zheng, Jason Cheatham, Mary Ann Zheng, Jing Acta Neuropathol Commun Research Niemann-Pick Type C1 (NPC1) disease is a fatal neurovisceral disorder caused by dysfunction of NPC1 protein, which plays a role in intracellular cholesterol trafficking. The cholesterol-chelating agent, 2-hydroxypropyl-β-cyclodextrin (HPβCD), is currently undergoing clinical trials for treatment of this disease. Though promising in alleviating neurological symptoms, HPβCD causes irreversible hearing loss in NPC1 patients and outer hair cell (OHC) death in animal models. We recently found that HPβCD-induced OHC death can be significantly alleviated in a mouse model lacking prestin, an OHC-specific motor protein required for the high sensitivity and sharp frequency selectivity of mammalian hearing. Since cholesterol status is known to influence prestin’s electromotility, we examined how prestin contributes to HPβCD-induced OHC death in the disease context using the NPC1 knockout (KO) mouse model (NPC1-KO). We found normal expression and localization of prestin in NPC1-KO OHCs. Whole-cell patch-clamp recordings revealed a significant depolarization of the voltage-operating point of prestin in NPC1-KO mice, suggesting reduced levels of cholesterol in the lateral membrane of OHCs that lack NPC1. OHC loss and elevated thresholds were found for high frequency regions in NPC1-KO mice, whose OHCs retained their sensitivity to HPβCD. To investigate whether prestin’s electromotile function contributes to HPβCD-induced OHC death, the prestin inhibitor salicylate was co-administered with HPβCD to WT and NPC1-KO mice. Neither oral nor intraperitoneal administration of salicylate mitigated HPβCD-induced OHC loss. To further determine the contribution of prestin’s electromotile function, a mouse model expressing a virtually nonelectromotile prestin protein (499-prestin) was subjected to HPβCD treatment. 499-prestin knockin mice showed no resistance to HPβCD-induced OHC loss. As 499-prestin maintains its ability to bind cholesterol, our data imply that HPβCD-induced OHC death is ascribed to the structural role of prestin in maintaining the OHC’s lateral membrane, rather than its motor function. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s40478-018-0599-9) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-24 /pmc/articles/PMC6151916/ /pubmed/30249300 http://dx.doi.org/10.1186/s40478-018-0599-9 Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhou, Yingjie
Takahashi, Satoe
Homma, Kazuaki
Duan, Chongwen
Zheng, Jason
Cheatham, Mary Ann
Zheng, Jing
The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity
title The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity
title_full The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity
title_fullStr The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity
title_full_unstemmed The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity
title_short The susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity
title_sort susceptibility of cochlear outer hair cells to cyclodextrin is not related to their electromotile activity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151916/
https://www.ncbi.nlm.nih.gov/pubmed/30249300
http://dx.doi.org/10.1186/s40478-018-0599-9
work_keys_str_mv AT zhouyingjie thesusceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT takahashisatoe thesusceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT hommakazuaki thesusceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT duanchongwen thesusceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT zhengjason thesusceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT cheathammaryann thesusceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT zhengjing thesusceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT zhouyingjie susceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT takahashisatoe susceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT hommakazuaki susceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT duanchongwen susceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT zhengjason susceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT cheathammaryann susceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity
AT zhengjing susceptibilityofcochlearouterhaircellstocyclodextrinisnotrelatedtotheirelectromotileactivity